サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1774768

デジタル心理療法の世界市場

Digital Psychotherapeutics

出版日
ページ情報
英文 467 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=150.39円
デジタル心理療法の世界市場
出版日: 2025年07月23日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 467 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

デジタル心理療法の世界市場は2030年までに40億米ドルに到達

2024年に16億米ドルと推定されるデジタル心理療法の世界市場は、分析期間2024-2030年にCAGR 16.8%で成長し、2030年には40億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである単剤療法ソリューションは、CAGR18.2%を記録し、分析期間終了時には30億米ドルに達すると予測されます。併用療法ソリューションセグメントの成長率は、分析期間中CAGR13.6％と推定されます。

米国市場は4億3,350万米ドルと推定、中国はCAGR22.4％で成長予測

米国のデジタル心理療法市場は、2024年に4億3,350万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに8億9,960万米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは22.4%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ12.3%と15.2%と予測されています。欧州では、ドイツがCAGR約13.4%で成長すると予測されています。

世界のデジタル心理療法市場- 主要動向と促進要因まとめ

デジタル心理療法はメンタルヘルスケアのギャップを埋められるか？

デジタル心理療法の台頭は、デジタルプラットフォームを通じてスケーラブルでエビデンスに基づいた治療介入を提供することで、メンタルヘルスケアに変革をもたらしつつあります。世界的にメンタルヘルス疾患が増加する中、従来の対面式セラピーサービスは、メンタルヘルス専門家の不足やアクセス障壁のために、需要を満たすのに苦労しています。メンタルヘルス向けデジタル治療（DTx）としても知られるデジタル心理療法は、人工知能（AI）、認知行動療法（CBT）、モバイルベースの介入を活用し、不安、うつ、PTSD、不眠症などの症状に対して臨床的に検証された治療を提供します。Woebot、SilverCloud、Wysaなどのアプリは、AI主導のチャットボットを使ってリアルタイムの感情サポートやガイド付きセラピープログラムを提供し、十分なサービスを受けていない人々にもメンタルヘルスケアをより身近なものにしています。さらに、遠隔治療プラットフォームは、デジタル心理療法をセラピストのライブサポートと統合し、治療のアドヒアランスと有効性を高めています。しかし、規制上の課題、患者のデータプライバシーに関する懸念、長期的な臨床検証の必要性などが、普及の主な障壁となっています。このような課題にもかかわらず、デジタル心理療法は、個別化された費用対効果の高い治療介入を提供し、世界のメンタルヘルスケアのギャップを埋める重要なソリューションとして浮上しています。

AIと機械学習はデジタル療法をどのように強化するのか？

人工知能（AI）と機械学習（ML）は、デジタル心理療法において、パーソナライズされた治療推奨、リアルタイムの気分追跡、適応的な治療モジュールを可能にし、変革的な役割を果たしています。AIを搭載したメンタルヘルス・プラットフォームは、ユーザーの行動、スピーチパターン、ウェアラブルデバイスからの生体データを分析し、感情的苦痛の初期兆候を検出し、適切な介入を推奨します。予測分析モデルは治療の進捗を評価し、臨床医が個々の反応に基づいて治療計画を改善できるよう支援します。さらに、自然言語処理（NLP）アルゴリズムにより、AI主導のチャットボットが治療会話をシミュレートし、ユーザーに即時の心理的サポートを提供することができます。しかし、AIを活用したデジタルセラピー・ソリューションは大きなメリットをもたらす一方で、アルゴリズムの偏り、誤診リスク、データセキュリティに関する懸念は依然として解決すべき課題となっています。AI技術が進化を続ける中、心理療法との統合により、治療の個別化、アドヒアランス率、メンタルヘルスケアの早期介入戦略の改善が期待されます。

バーチャルリアリティ（VR）とゲーミフィケーションはメンタルヘルスのアウトカムを改善できるか？

仮想現実（VR）とゲーミフィケーションは、デジタル心理療法における革新的なツールとして台頭してきており、ユーザーのエンゲージメントと治療効果を高めています。VRを利用した暴露療法は、不安障害、恐怖症、PTSDの治療に利用されており、患者が恐怖に直面し、対処できるよう、制御されたシミュレーション環境に没頭できるようになっています。報酬システムやインタラクティブなエクササイズといったゲーミフィケーションの要素は、メンタルヘルス介入をより魅力的なものにすることで、治療のアドヒアランスを向上させています。SuperBetterやMindEaseのようなアプリは、ゲームベースの仕組みを使って、前向きな行動の変化や回復力を高める練習を促しています。さらに、バイオフィードバックと統合されたVRセラピーは、リアルタイムのストレスモニタリングを可能にし、マインドフルネス技術を通じてユーザーの感情的反応を調整するのに役立っています。潜在的な利点があるにもかかわらず、手頃な価格、アクセシビリティ、特殊なハードウェアの必要性といった課題が、依然として導入の障壁となっています。しかし、VRやゲーミフィケーション技術が進歩すれば、デジタル心理療法に革命をもたらし、メンタルヘルス治療をより没入的で効果的なものにすると期待されています。

デジタル心理療法市場の成長の原動力は？

デジタル心理療法市場の成長は、メンタルヘルス障害の有病率の増加、メンタルヘルス専門家の不足、AI主導の治療ソリューションの受け入れ拡大など、いくつかの要因によってもたらされます。モバイルヘルス（mヘルス）アプリケーションとウェアラブル技術の進歩は、リアルタイムのメンタルヘルス追跡と介入を可能にしています。デジタル治療薬に対する規制上の支援と、デジタルメンタルヘルス・ソリューションに対する償還政策の増加は、採用をさらに加速させています。遠隔医療やバーチャル・セラピー・セッションの人気が高まっていることも、メンタルヘルスケアの主流にデジタル心理療法を組み込んでいます。さらに、メンタルウェルネスや企業のメンタルヘルスプログラムが重視されるようになり、拡張性のあるデジタルファーストのソリューションに対する需要が高まっています。テクノロジーの向上が進むにつれ、デジタル心理療法は、セラピーをより身近に、データ主導で、パーソナライズされたものにし、メンタルヘルスの将来において重要な役割を果たすことが期待されています。

セグメント

ソリューション（単剤療法ソリューション、併用療法ソリューション）、適応症（恐怖症・不安障害適応症、精神病性障害適応症、その他の適応症）、ビジネスモデル（患者・消費者直販ビジネスモデル、企業間ビジネスモデル）、アプリケーション（予防アプリケーション、管理アプリケーション、治療アプリケーション）

調査対象企業の例

  • 2Morrow
  • Big Health
  • BetterHelp
  • Cara Care
  • Click Therapeutics
  • Dialogue Health Technologies
  • Happify Health
  • Headspace
  • HelloBetter
  • Limbic
  • Livongo Health
  • Modern Health
  • Noom
  • Pear Therapeutics
  • Rejoyn
  • SilverCloud Health
  • Talkspace
  • Tata Elxsi
  • Teladoc Health
  • Woebot Health

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP30511

Global Digital Psychotherapeutics Market to Reach US$4.0 Billion by 2030

The global market for Digital Psychotherapeutics estimated at US$1.6 Billion in the year 2024, is expected to reach US$4.0 Billion by 2030, growing at a CAGR of 16.8% over the analysis period 2024-2030. Monotherapy Solution, one of the segments analyzed in the report, is expected to record a 18.2% CAGR and reach US$3.0 Billion by the end of the analysis period. Growth in the Combination Therapy Solution segment is estimated at 13.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$433.5 Million While China is Forecast to Grow at 22.4% CAGR

The Digital Psychotherapeutics market in the U.S. is estimated at US$433.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$899.6 Million by the year 2030 trailing a CAGR of 22.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 12.3% and 15.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 13.4% CAGR.

Global Digital Psychotherapeutics Market - Key Trends & Drivers Summarized

Can Digital Psychotherapeutics Bridge the Mental Healthcare Gap?

The rise of digital psychotherapeutics is transforming mental healthcare by providing scalable, evidence-based therapeutic interventions through digital platforms. With global mental health disorders on the rise, traditional in-person therapy services are struggling to meet demand due to shortages of mental health professionals and accessibility barriers. Digital psychotherapeutics, also known as digital therapeutics (DTx) for mental health, leverage artificial intelligence (AI), cognitive behavioral therapy (CBT), and mobile-based interventions to provide clinically validated treatments for conditions such as anxiety, depression, PTSD, and insomnia. Apps such as Woebot, SilverCloud, and Wysa use AI-driven chatbots to offer real-time emotional support and guided therapy programs, making mental healthcare more accessible to underserved populations. Additionally, teletherapy platforms integrate digital psychotherapeutics with live therapist support, enhancing treatment adherence and effectiveness. However, regulatory challenges, concerns over patient data privacy, and the need for long-term clinical validation remain key barriers to widespread adoption. Despite these challenges, digital psychotherapeutics are emerging as a critical solution to bridge the global mental healthcare gap, offering personalized and cost-effective therapeutic interventions.

How Are AI and Machine Learning Enhancing Digital Therapy?

Artificial intelligence (AI) and machine learning (ML) are playing a transformative role in digital psychotherapeutics, enabling personalized treatment recommendations, real-time mood tracking, and adaptive therapy modules. AI-powered mental health platforms analyze user behavior, speech patterns, and biometric data from wearable devices to detect early signs of emotional distress and recommend appropriate interventions. Predictive analytics models assess therapy progress, helping clinicians refine treatment plans based on individual responses. Additionally, natural language processing (NLP) algorithms enable AI-driven chatbots to simulate therapeutic conversations, providing users with immediate psychological support. However, while AI-driven digital therapy solutions offer significant benefits, concerns regarding algorithm bias, misdiagnosis risks, and data security remain challenges that need to be addressed. As AI technology continues to evolve, its integration with psychotherapeutics is expected to improve treatment personalization, adherence rates, and early intervention strategies in mental healthcare.

Can Virtual Reality (VR) and Gamification Improve Mental Health Outcomes?

Virtual reality (VR) and gamification are emerging as innovative tools in digital psychotherapeutics, enhancing user engagement and therapy effectiveness. VR-based exposure therapy is being used to treat anxiety disorders, phobias, and PTSD by immersing patients in controlled, simulated environments that help them confront and manage their fears. Gamification elements, such as reward systems and interactive exercises, are improving therapy adherence by making mental health interventions more engaging. Apps like SuperBetter and MindEase use game-based mechanics to encourage positive behavioral changes and resilience-building exercises. Additionally, biofeedback-integrated VR therapy is enabling real-time stress monitoring, helping users regulate their emotional responses through mindfulness techniques. Despite the potential benefits, challenges such as affordability, accessibility, and the need for specialized hardware remain barriers to adoption. However, as VR and gamification technologies advance, they are expected to revolutionize digital psychotherapeutics, making mental health treatment more immersive and effective.

What Is Driving the Growth of the Digital Psychotherapeutics Market?

The growth in the digital psychotherapeutics market is driven by several factors, including the increasing prevalence of mental health disorders, the shortage of mental health professionals, and the growing acceptance of AI-driven therapy solutions. Advancements in mobile health (mHealth) applications and wearable technology are enabling real-time mental health tracking and intervention. Regulatory support for digital therapeutics and increasing reimbursement policies for digital mental health solutions are further accelerating adoption. The rising popularity of telehealth and virtual therapy sessions is also integrating digital psychotherapeutics into mainstream mental healthcare. Additionally, the growing emphasis on mental wellness and corporate mental health programs is driving demand for scalable, digital-first solutions. As technology continues to improve, digital psychotherapeutics are expected to play a crucial role in the future of mental healthcare, making therapy more accessible, data-driven, and personalized.

SCOPE OF STUDY:

The report analyzes the Digital Psychotherapeutics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Solution (Monotherapy Solution, Combination Therapy Solution); Indication (Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication, Other Indications); Business Model (Direct-To-Patients / Consumers Business Model, Business-to-Business Business Model); Application (Prevention Application, Management Application, Treatment Application)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

  • 2Morrow
  • Big Health
  • BetterHelp
  • Cara Care
  • Click Therapeutics
  • Dialogue Health Technologies
  • Happify Health
  • Headspace
  • HelloBetter
  • Limbic
  • Livongo Health
  • Modern Health
  • Noom
  • Pear Therapeutics
  • Rejoyn
  • SilverCloud Health
  • Talkspace
  • Tata Elxsi
  • Teladoc Health
  • Woebot Health

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Digital Psychotherapeutics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Prevalence of Mental Health Disorders Drives Demand for Digital Psychotherapeutics Solutions
    • Surge in Consumer Adoption of Digital Health Platforms Expands Addressable Market for Digital Psychotherapeutic Tools
    • Technological Advancements in Artificial Intelligence and Machine Learning Enhance the Effectiveness of Digital Psychotherapeutics
    • Rising Demand for Personalized and Accessible Mental Health Solutions Strengthens the Business Case for Digital Psychotherapeutics
    • Increased Focus on Mental Health and Wellbeing by Governments and Healthcare Providers Accelerates the Adoption of Digital Psychotherapeutics
    • The Growth of Remote and Telehealth Services Expands Opportunities for Digital Psychotherapeutics in Virtual Care Settings
    • The Rise of Wearable Devices and Mobile Applications for Mental Health Management Drives Growth in Digital Psychotherapeutics Solutions
    • Expansion of Regulatory Support for Digital Therapeutics Propels Adoption of Digital Psychotherapeutics in Mainstream Healthcare
    • The Growing Role of Behavioral Health in Overall Wellness Programs Expands the Reach of Digital Psychotherapeutics to Broader Audiences
    • Increasing Public and Corporate Investment in Mental Health Technology Drives Market Opportunities for Digital Psychotherapeutics Solutions
    • The Shift Toward Preventive Healthcare and Early Intervention Drives Adoption of Digital Psychotherapeutics for Mental Wellness
    • Rising Awareness of the Benefits of Digital Health and Self-Help Solutions Strengthens Market Demand for Digital Psychotherapeutics Platforms
    • The Emergence of Cognitive Behavioral Therapy (CBT) and Other Evidence-Based Techniques in Digital Form Drives Growth in Digital Psychotherapeutics
    • Integration of Digital Psychotherapeutics with Traditional Mental Health Services Expands Adoption Among Therapists and Psychologists
    • The Growth of Digital Therapeutics in the Treatment of Chronic Conditions, such as Depression and Anxiety, Expands Opportunities in Digital Psychotherapeutics
    • Increased Focus on Data Privacy and Security in Digital Health Solutions Drives Consumer Confidence and Adoption of Digital Psychotherapeutics
    • The Need for Scalable and Cost-Effective Mental Health Solutions in Resource-Constrained Environments Accelerates the Use of Digital Psychotherapeutics
    • Rising Popularity of Personalized Mental Health Programs, Powered by Data and AI, Expands Addressable Market for Digital Psychotherapeutics
    • The Integration of Gamification and Interactive Features in Digital Psychotherapeutics Solutions Enhances Patient Engagement and Retention
    • The Expansion of Digital Psychotherapeutics Across International Markets Creates Global Market Opportunities for Mental Health Solutions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Digital Psychotherapeutics Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Digital Psychotherapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Digital Psychotherapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Monotherapy Solution by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Monotherapy Solution by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Monotherapy Solution by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Combination Therapy Solution by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Combination Therapy Solution by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Combination Therapy Solution by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Treatment Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Treatment Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Treatment Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Prevention Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Prevention Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Prevention Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Management Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Management Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Management Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Phobias & Anxiety Disorders Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Phobias & Anxiety Disorders Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Phobias & Anxiety Disorders Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Psychotic Disorders Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Psychotic Disorders Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Psychotic Disorders Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Other Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Direct-To-Patients / Consumers Business Model by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Direct-To-Patients / Consumers Business Model by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Direct-To-Patients / Consumers Business Model by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Business-to-Business Business Model by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Business-to-Business Business Model by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Business-to-Business Business Model by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Digital Psychotherapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Digital Psychotherapeutics by Solution - Percentage Breakdown of Value Sales for Monotherapy Solution and Combination Therapy Solution for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Digital Psychotherapeutics by Application - Percentage Breakdown of Value Sales for Treatment Application, Prevention Application and Management Application for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Digital Psychotherapeutics by Indication - Percentage Breakdown of Value Sales for Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Digital Psychotherapeutics by Business Model - Percentage Breakdown of Value Sales for Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Digital Psychotherapeutics by Solution - Percentage Breakdown of Value Sales for Monotherapy Solution and Combination Therapy Solution for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Digital Psychotherapeutics by Application - Percentage Breakdown of Value Sales for Treatment Application, Prevention Application and Management Application for the Years 2015, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Digital Psychotherapeutics by Indication - Percentage Breakdown of Value Sales for Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for Digital Psychotherapeutics by Business Model - Percentage Breakdown of Value Sales for Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model for the Years 2015, 2025 & 2030
  • JAPAN
    • Digital Psychotherapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Digital Psychotherapeutics by Solution - Percentage Breakdown of Value Sales for Monotherapy Solution and Combination Therapy Solution for the Years 2015, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Digital Psychotherapeutics by Application - Percentage Breakdown of Value Sales for Treatment Application, Prevention Application and Management Application for the Years 2015, 2025 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Japan 15-Year Perspective for Digital Psychotherapeutics by Indication - Percentage Breakdown of Value Sales for Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Japan 15-Year Perspective for Digital Psychotherapeutics by Business Model - Percentage Breakdown of Value Sales for Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model for the Years 2015, 2025 & 2030
  • CHINA
    • Digital Psychotherapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 71: China Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for Digital Psychotherapeutics by Solution - Percentage Breakdown of Value Sales for Monotherapy Solution and Combination Therapy Solution for the Years 2015, 2025 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: China 15-Year Perspective for Digital Psychotherapeutics by Application - Percentage Breakdown of Value Sales for Treatment Application, Prevention Application and Management Application for the Years 2015, 2025 & 2030
    • TABLE 77: China Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: China Historic Review for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: China 15-Year Perspective for Digital Psychotherapeutics by Indication - Percentage Breakdown of Value Sales for Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 80: China Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: China Historic Review for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: China 15-Year Perspective for Digital Psychotherapeutics by Business Model - Percentage Breakdown of Value Sales for Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model for the Years 2015, 2025 & 2030
  • EUROPE
    • Digital Psychotherapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Digital Psychotherapeutics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for Digital Psychotherapeutics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Europe 15-Year Perspective for Digital Psychotherapeutics by Solution - Percentage Breakdown of Value Sales for Monotherapy Solution and Combination Therapy Solution for the Years 2015, 2025 & 2030
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Europe 15-Year Perspective for Digital Psychotherapeutics by Application - Percentage Breakdown of Value Sales for Treatment Application, Prevention Application and Management Application for the Years 2015, 2025 & 2030
    • TABLE 92: Europe Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Europe 15-Year Perspective for Digital Psychotherapeutics by Indication - Percentage Breakdown of Value Sales for Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 95: Europe Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Europe Historic Review for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Europe 15-Year Perspective for Digital Psychotherapeutics by Business Model - Percentage Breakdown of Value Sales for Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model for the Years 2015, 2025 & 2030
  • FRANCE
    • Digital Psychotherapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 98: France Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: France Historic Review for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: France 15-Year Perspective for Digital Psychotherapeutics by Solution - Percentage Breakdown of Value Sales for Monotherapy Solution and Combination Therapy Solution for the Years 2015, 2025 & 2030
    • TABLE 101: France Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: France Historic Review for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: France 15-Year Perspective for Digital Psychotherapeutics by Application - Percentage Breakdown of Value Sales for Treatment Application, Prevention Application and Management Application for the Years 2015, 2025 & 2030
    • TABLE 104: France Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: France Historic Review for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: France 15-Year Perspective for Digital Psychotherapeutics by Indication - Percentage Breakdown of Value Sales for Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 107: France Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: France Historic Review for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: France 15-Year Perspective for Digital Psychotherapeutics by Business Model - Percentage Breakdown of Value Sales for Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model for the Years 2015, 2025 & 2030
  • GERMANY
    • Digital Psychotherapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 110: Germany Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Germany Historic Review for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Germany 15-Year Perspective for Digital Psychotherapeutics by Solution - Percentage Breakdown of Value Sales for Monotherapy Solution and Combination Therapy Solution for the Years 2015, 2025 & 2030
    • TABLE 113: Germany Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Germany Historic Review for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Germany 15-Year Perspective for Digital Psychotherapeutics by Application - Percentage Breakdown of Value Sales for Treatment Application, Prevention Application and Management Application for the Years 2015, 2025 & 2030
    • TABLE 116: Germany Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Germany Historic Review for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Germany 15-Year Perspective for Digital Psychotherapeutics by Indication - Percentage Breakdown of Value Sales for Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 119: Germany Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Germany Historic Review for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Germany 15-Year Perspective for Digital Psychotherapeutics by Business Model - Percentage Breakdown of Value Sales for Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 122: Italy Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Italy Historic Review for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Italy 15-Year Perspective for Digital Psychotherapeutics by Solution - Percentage Breakdown of Value Sales for Monotherapy Solution and Combination Therapy Solution for the Years 2015, 2025 & 2030
    • TABLE 125: Italy Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Italy Historic Review for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Italy 15-Year Perspective for Digital Psychotherapeutics by Application - Percentage Breakdown of Value Sales for Treatment Application, Prevention Application and Management Application for the Years 2015, 2025 & 2030
    • TABLE 128: Italy Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Italy Historic Review for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Italy 15-Year Perspective for Digital Psychotherapeutics by Indication - Percentage Breakdown of Value Sales for Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 131: Italy Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Italy Historic Review for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Italy 15-Year Perspective for Digital Psychotherapeutics by Business Model - Percentage Breakdown of Value Sales for Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Digital Psychotherapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 134: UK Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: UK Historic Review for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: UK 15-Year Perspective for Digital Psychotherapeutics by Solution - Percentage Breakdown of Value Sales for Monotherapy Solution and Combination Therapy Solution for the Years 2015, 2025 & 2030
    • TABLE 137: UK Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: UK Historic Review for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: UK 15-Year Perspective for Digital Psychotherapeutics by Application - Percentage Breakdown of Value Sales for Treatment Application, Prevention Application and Management Application for the Years 2015, 2025 & 2030
    • TABLE 140: UK Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: UK Historic Review for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: UK 15-Year Perspective for Digital Psychotherapeutics by Indication - Percentage Breakdown of Value Sales for Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 143: UK Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: UK Historic Review for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: UK 15-Year Perspective for Digital Psychotherapeutics by Business Model - Percentage Breakdown of Value Sales for Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 146: Spain Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Spain Historic Review for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Spain 15-Year Perspective for Digital Psychotherapeutics by Solution - Percentage Breakdown of Value Sales for Monotherapy Solution and Combination Therapy Solution for the Years 2015, 2025 & 2030
    • TABLE 149: Spain Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Spain Historic Review for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Spain 15-Year Perspective for Digital Psychotherapeutics by Application - Percentage Breakdown of Value Sales for Treatment Application, Prevention Application and Management Application for the Years 2015, 2025 & 2030
    • TABLE 152: Spain Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Spain Historic Review for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Spain 15-Year Perspective for Digital Psychotherapeutics by Indication - Percentage Breakdown of Value Sales for Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 155: Spain Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Spain Historic Review for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Spain 15-Year Perspective for Digital Psychotherapeutics by Business Model - Percentage Breakdown of Value Sales for Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 158: Russia Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Russia Historic Review for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Russia 15-Year Perspective for Digital Psychotherapeutics by Solution - Percentage Breakdown of Value Sales for Monotherapy Solution and Combination Therapy Solution for the Years 2015, 2025 & 2030
    • TABLE 161: Russia Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Russia Historic Review for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Russia 15-Year Perspective for Digital Psychotherapeutics by Application - Percentage Breakdown of Value Sales for Treatment Application, Prevention Application and Management Application for the Years 2015, 2025 & 2030
    • TABLE 164: Russia Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Russia Historic Review for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Russia 15-Year Perspective for Digital Psychotherapeutics by Indication - Percentage Breakdown of Value Sales for Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 167: Russia Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Russia Historic Review for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Russia 15-Year Perspective for Digital Psychotherapeutics by Business Model - Percentage Breakdown of Value Sales for Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 170: Rest of Europe Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Rest of Europe Historic Review for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Rest of Europe 15-Year Perspective for Digital Psychotherapeutics by Solution - Percentage Breakdown of Value Sales for Monotherapy Solution and Combination Therapy Solution for the Years 2015, 2025 & 2030
    • TABLE 173: Rest of Europe Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Rest of Europe Historic Review for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Rest of Europe 15-Year Perspective for Digital Psychotherapeutics by Application - Percentage Breakdown of Value Sales for Treatment Application, Prevention Application and Management Application for the Years 2015, 2025 & 2030
    • TABLE 176: Rest of Europe Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Rest of Europe Historic Review for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Rest of Europe 15-Year Perspective for Digital Psychotherapeutics by Indication - Percentage Breakdown of Value Sales for Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 179: Rest of Europe Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of Europe Historic Review for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Rest of Europe 15-Year Perspective for Digital Psychotherapeutics by Business Model - Percentage Breakdown of Value Sales for Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Digital Psychotherapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 182: Asia-Pacific Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 183: Asia-Pacific Historic Review for Digital Psychotherapeutics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Asia-Pacific 15-Year Perspective for Digital Psychotherapeutics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 185: Asia-Pacific Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Asia-Pacific Historic Review for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Asia-Pacific 15-Year Perspective for Digital Psychotherapeutics by Solution - Percentage Breakdown of Value Sales for Monotherapy Solution and Combination Therapy Solution for the Years 2015, 2025 & 2030
    • TABLE 188: Asia-Pacific Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Asia-Pacific Historic Review for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Asia-Pacific 15-Year Perspective for Digital Psychotherapeutics by Application - Percentage Breakdown of Value Sales for Treatment Application, Prevention Application and Management Application for the Years 2015, 2025 & 2030
    • TABLE 191: Asia-Pacific Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Asia-Pacific Historic Review for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Asia-Pacific 15-Year Perspective for Digital Psychotherapeutics by Indication - Percentage Breakdown of Value Sales for Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Asia-Pacific Historic Review for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Asia-Pacific 15-Year Perspective for Digital Psychotherapeutics by Business Model - Percentage Breakdown of Value Sales for Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Digital Psychotherapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 197: Australia Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Australia Historic Review for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Australia 15-Year Perspective for Digital Psychotherapeutics by Solution - Percentage Breakdown of Value Sales for Monotherapy Solution and Combination Therapy Solution for the Years 2015, 2025 & 2030
    • TABLE 200: Australia Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Australia Historic Review for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Australia 15-Year Perspective for Digital Psychotherapeutics by Application - Percentage Breakdown of Value Sales for Treatment Application, Prevention Application and Management Application for the Years 2015, 2025 & 2030
    • TABLE 203: Australia Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Australia Historic Review for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Australia 15-Year Perspective for Digital Psychotherapeutics by Indication - Percentage Breakdown of Value Sales for Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 206: Australia Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Australia Historic Review for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Australia 15-Year Perspective for Digital Psychotherapeutics by Business Model - Percentage Breakdown of Value Sales for Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model for the Years 2015, 2025 & 2030
  • INDIA
    • Digital Psychotherapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 209: India Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: India Historic Review for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: India 15-Year Perspective for Digital Psychotherapeutics by Solution - Percentage Breakdown of Value Sales for Monotherapy Solution and Combination Therapy Solution for the Years 2015, 2025 & 2030
    • TABLE 212: India Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: India Historic Review for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: India 15-Year Perspective for Digital Psychotherapeutics by Application - Percentage Breakdown of Value Sales for Treatment Application, Prevention Application and Management Application for the Years 2015, 2025 & 2030
    • TABLE 215: India Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: India Historic Review for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: India 15-Year Perspective for Digital Psychotherapeutics by Indication - Percentage Breakdown of Value Sales for Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 218: India Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: India Historic Review for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: India 15-Year Perspective for Digital Psychotherapeutics by Business Model - Percentage Breakdown of Value Sales for Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 221: South Korea Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: South Korea Historic Review for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: South Korea 15-Year Perspective for Digital Psychotherapeutics by Solution - Percentage Breakdown of Value Sales for Monotherapy Solution and Combination Therapy Solution for the Years 2015, 2025 & 2030
    • TABLE 224: South Korea Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: South Korea Historic Review for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 226: South Korea 15-Year Perspective for Digital Psychotherapeutics by Application - Percentage Breakdown of Value Sales for Treatment Application, Prevention Application and Management Application for the Years 2015, 2025 & 2030
    • TABLE 227: South Korea Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: South Korea Historic Review for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 229: South Korea 15-Year Perspective for Digital Psychotherapeutics by Indication - Percentage Breakdown of Value Sales for Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 230: South Korea Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: South Korea Historic Review for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 232: South Korea 15-Year Perspective for Digital Psychotherapeutics by Business Model - Percentage Breakdown of Value Sales for Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 233: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Asia-Pacific Historic Review for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Asia-Pacific 15-Year Perspective for Digital Psychotherapeutics by Solution - Percentage Breakdown of Value Sales for Monotherapy Solution and Combination Therapy Solution for the Years 2015, 2025 & 2030
    • TABLE 236: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Asia-Pacific Historic Review for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Asia-Pacific 15-Year Perspective for Digital Psychotherapeutics by Application - Percentage Breakdown of Value Sales for Treatment Application, Prevention Application and Management Application for the Years 2015, 2025 & 2030
    • TABLE 239: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Asia-Pacific Historic Review for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Asia-Pacific 15-Year Perspective for Digital Psychotherapeutics by Indication - Percentage Breakdown of Value Sales for Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 242: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Asia-Pacific Historic Review for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 244: Rest of Asia-Pacific 15-Year Perspective for Digital Psychotherapeutics by Business Model - Percentage Breakdown of Value Sales for Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Digital Psychotherapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 245: Latin America Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 246: Latin America Historic Review for Digital Psychotherapeutics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 247: Latin America 15-Year Perspective for Digital Psychotherapeutics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 248: Latin America Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Latin America Historic Review for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 250: Latin America 15-Year Perspective for Digital Psychotherapeutics by Solution - Percentage Breakdown of Value Sales for Monotherapy Solution and Combination Therapy Solution for the Years 2015, 2025 & 2030
    • TABLE 251: Latin America Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Latin America Historic Review for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 253: Latin America 15-Year Perspective for Digital Psychotherapeutics by Application - Percentage Breakdown of Value Sales for Treatment Application, Prevention Application and Management Application for the Years 2015, 2025 & 2030
    • TABLE 254: Latin America Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Latin America Historic Review for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 256: Latin America 15-Year Perspective for Digital Psychotherapeutics by Indication - Percentage Breakdown of Value Sales for Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 257: Latin America Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Latin America Historic Review for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 259: Latin America 15-Year Perspective for Digital Psychotherapeutics by Business Model - Percentage Breakdown of Value Sales for Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 260: Argentina Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Argentina Historic Review for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 262: Argentina 15-Year Perspective for Digital Psychotherapeutics by Solution - Percentage Breakdown of Value Sales for Monotherapy Solution and Combination Therapy Solution for the Years 2015, 2025 & 2030
    • TABLE 263: Argentina Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Argentina Historic Review for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 265: Argentina 15-Year Perspective for Digital Psychotherapeutics by Application - Percentage Breakdown of Value Sales for Treatment Application, Prevention Application and Management Application for the Years 2015, 2025 & 2030
    • TABLE 266: Argentina Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Argentina Historic Review for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 268: Argentina 15-Year Perspective for Digital Psychotherapeutics by Indication - Percentage Breakdown of Value Sales for Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 269: Argentina Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Argentina Historic Review for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 271: Argentina 15-Year Perspective for Digital Psychotherapeutics by Business Model - Percentage Breakdown of Value Sales for Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 272: Brazil Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Brazil Historic Review for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 274: Brazil 15-Year Perspective for Digital Psychotherapeutics by Solution - Percentage Breakdown of Value Sales for Monotherapy Solution and Combination Therapy Solution for the Years 2015, 2025 & 2030
    • TABLE 275: Brazil Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Brazil Historic Review for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 277: Brazil 15-Year Perspective for Digital Psychotherapeutics by Application - Percentage Breakdown of Value Sales for Treatment Application, Prevention Application and Management Application for the Years 2015, 2025 & 2030
    • TABLE 278: Brazil Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Brazil Historic Review for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 280: Brazil 15-Year Perspective for Digital Psychotherapeutics by Indication - Percentage Breakdown of Value Sales for Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 281: Brazil Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Brazil Historic Review for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 283: Brazil 15-Year Perspective for Digital Psychotherapeutics by Business Model - Percentage Breakdown of Value Sales for Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 284: Mexico Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Mexico Historic Review for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 286: Mexico 15-Year Perspective for Digital Psychotherapeutics by Solution - Percentage Breakdown of Value Sales for Monotherapy Solution and Combination Therapy Solution for the Years 2015, 2025 & 2030
    • TABLE 287: Mexico Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Mexico Historic Review for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 289: Mexico 15-Year Perspective for Digital Psychotherapeutics by Application - Percentage Breakdown of Value Sales for Treatment Application, Prevention Application and Management Application for the Years 2015, 2025 & 2030
    • TABLE 290: Mexico Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Mexico Historic Review for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 292: Mexico 15-Year Perspective for Digital Psychotherapeutics by Indication - Percentage Breakdown of Value Sales for Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 293: Mexico Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Mexico Historic Review for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 295: Mexico 15-Year Perspective for Digital Psychotherapeutics by Business Model - Percentage Breakdown of Value Sales for Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 296: Rest of Latin America Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Latin America Historic Review for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 298: Rest of Latin America 15-Year Perspective for Digital Psychotherapeutics by Solution - Percentage Breakdown of Value Sales for Monotherapy Solution and Combination Therapy Solution for the Years 2015, 2025 & 2030
    • TABLE 299: Rest of Latin America Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Rest of Latin America Historic Review for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 301: Rest of Latin America 15-Year Perspective for Digital Psychotherapeutics by Application - Percentage Breakdown of Value Sales for Treatment Application, Prevention Application and Management Application for the Years 2015, 2025 & 2030
    • TABLE 302: Rest of Latin America Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Rest of Latin America Historic Review for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 304: Rest of Latin America 15-Year Perspective for Digital Psychotherapeutics by Indication - Percentage Breakdown of Value Sales for Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 305: Rest of Latin America Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Rest of Latin America Historic Review for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 307: Rest of Latin America 15-Year Perspective for Digital Psychotherapeutics by Business Model - Percentage Breakdown of Value Sales for Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Digital Psychotherapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 308: Middle East Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 309: Middle East Historic Review for Digital Psychotherapeutics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 310: Middle East 15-Year Perspective for Digital Psychotherapeutics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 311: Middle East Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Middle East Historic Review for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 313: Middle East 15-Year Perspective for Digital Psychotherapeutics by Solution - Percentage Breakdown of Value Sales for Monotherapy Solution and Combination Therapy Solution for the Years 2015, 2025 & 2030
    • TABLE 314: Middle East Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 315: Middle East Historic Review for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 316: Middle East 15-Year Perspective for Digital Psychotherapeutics by Application - Percentage Breakdown of Value Sales for Treatment Application, Prevention Application and Management Application for the Years 2015, 2025 & 2030
    • TABLE 317: Middle East Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 318: Middle East Historic Review for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 319: Middle East 15-Year Perspective for Digital Psychotherapeutics by Indication - Percentage Breakdown of Value Sales for Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 320: Middle East Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 321: Middle East Historic Review for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 322: Middle East 15-Year Perspective for Digital Psychotherapeutics by Business Model - Percentage Breakdown of Value Sales for Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 323: Iran Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 324: Iran Historic Review for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 325: Iran 15-Year Perspective for Digital Psychotherapeutics by Solution - Percentage Breakdown of Value Sales for Monotherapy Solution and Combination Therapy Solution for the Years 2015, 2025 & 2030
    • TABLE 326: Iran Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 327: Iran Historic Review for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 328: Iran 15-Year Perspective for Digital Psychotherapeutics by Application - Percentage Breakdown of Value Sales for Treatment Application, Prevention Application and Management Application for the Years 2015, 2025 & 2030
    • TABLE 329: Iran Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 330: Iran Historic Review for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 331: Iran 15-Year Perspective for Digital Psychotherapeutics by Indication - Percentage Breakdown of Value Sales for Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 332: Iran Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 333: Iran Historic Review for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 334: Iran 15-Year Perspective for Digital Psychotherapeutics by Business Model - Percentage Breakdown of Value Sales for Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 335: Israel Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 336: Israel Historic Review for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 337: Israel 15-Year Perspective for Digital Psychotherapeutics by Solution - Percentage Breakdown of Value Sales for Monotherapy Solution and Combination Therapy Solution for the Years 2015, 2025 & 2030
    • TABLE 338: Israel Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 339: Israel Historic Review for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 340: Israel 15-Year Perspective for Digital Psychotherapeutics by Application - Percentage Breakdown of Value Sales for Treatment Application, Prevention Application and Management Application for the Years 2015, 2025 & 2030
    • TABLE 341: Israel Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 342: Israel Historic Review for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 343: Israel 15-Year Perspective for Digital Psychotherapeutics by Indication - Percentage Breakdown of Value Sales for Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 344: Israel Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 345: Israel Historic Review for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 346: Israel 15-Year Perspective for Digital Psychotherapeutics by Business Model - Percentage Breakdown of Value Sales for Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 347: Saudi Arabia Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 348: Saudi Arabia Historic Review for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 349: Saudi Arabia 15-Year Perspective for Digital Psychotherapeutics by Solution - Percentage Breakdown of Value Sales for Monotherapy Solution and Combination Therapy Solution for the Years 2015, 2025 & 2030
    • TABLE 350: Saudi Arabia Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 351: Saudi Arabia Historic Review for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 352: Saudi Arabia 15-Year Perspective for Digital Psychotherapeutics by Application - Percentage Breakdown of Value Sales for Treatment Application, Prevention Application and Management Application for the Years 2015, 2025 & 2030
    • TABLE 353: Saudi Arabia Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 354: Saudi Arabia Historic Review for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 355: Saudi Arabia 15-Year Perspective for Digital Psychotherapeutics by Indication - Percentage Breakdown of Value Sales for Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 356: Saudi Arabia Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 357: Saudi Arabia Historic Review for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 358: Saudi Arabia 15-Year Perspective for Digital Psychotherapeutics by Business Model - Percentage Breakdown of Value Sales for Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 359: UAE Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 360: UAE Historic Review for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 361: UAE 15-Year Perspective for Digital Psychotherapeutics by Solution - Percentage Breakdown of Value Sales for Monotherapy Solution and Combination Therapy Solution for the Years 2015, 2025 & 2030
    • TABLE 362: UAE Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 363: UAE Historic Review for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 364: UAE 15-Year Perspective for Digital Psychotherapeutics by Application - Percentage Breakdown of Value Sales for Treatment Application, Prevention Application and Management Application for the Years 2015, 2025 & 2030
    • TABLE 365: UAE Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 366: UAE Historic Review for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 367: UAE 15-Year Perspective for Digital Psychotherapeutics by Indication - Percentage Breakdown of Value Sales for Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 368: UAE Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 369: UAE Historic Review for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 370: UAE 15-Year Perspective for Digital Psychotherapeutics by Business Model - Percentage Breakdown of Value Sales for Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 371: Rest of Middle East Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 372: Rest of Middle East Historic Review for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 373: Rest of Middle East 15-Year Perspective for Digital Psychotherapeutics by Solution - Percentage Breakdown of Value Sales for Monotherapy Solution and Combination Therapy Solution for the Years 2015, 2025 & 2030
    • TABLE 374: Rest of Middle East Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 375: Rest of Middle East Historic Review for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 376: Rest of Middle East 15-Year Perspective for Digital Psychotherapeutics by Application - Percentage Breakdown of Value Sales for Treatment Application, Prevention Application and Management Application for the Years 2015, 2025 & 2030
    • TABLE 377: Rest of Middle East Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 378: Rest of Middle East Historic Review for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 379: Rest of Middle East 15-Year Perspective for Digital Psychotherapeutics by Indication - Percentage Breakdown of Value Sales for Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 380: Rest of Middle East Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 381: Rest of Middle East Historic Review for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 382: Rest of Middle East 15-Year Perspective for Digital Psychotherapeutics by Business Model - Percentage Breakdown of Value Sales for Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model for the Years 2015, 2025 & 2030
  • AFRICA
    • Digital Psychotherapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 383: Africa Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 384: Africa Historic Review for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 385: Africa 15-Year Perspective for Digital Psychotherapeutics by Solution - Percentage Breakdown of Value Sales for Monotherapy Solution and Combination Therapy Solution for the Years 2015, 2025 & 2030
    • TABLE 386: Africa Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 387: Africa Historic Review for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 388: Africa 15-Year Perspective for Digital Psychotherapeutics by Application - Percentage Breakdown of Value Sales for Treatment Application, Prevention Application and Management Application for the Years 2015, 2025 & 2030
    • TABLE 389: Africa Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 390: Africa Historic Review for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 391: Africa 15-Year Perspective for Digital Psychotherapeutics by Indication - Percentage Breakdown of Value Sales for Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 392: Africa Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 393: Africa Historic Review for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 394: Africa 15-Year Perspective for Digital Psychotherapeutics by Business Model - Percentage Breakdown of Value Sales for Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model for the Years 2015, 2025 & 2030

IV. COMPETITION